Compare SoFi Technologies Inc (SOFI) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoFi Technologies Inc vs 10X Genomics Inc — how do they compare? SoFi Technologies Inc trades at $18.21 (market cap $23.22B), while 10X Genomics Inc trades at $58.6 (market cap $7.61B). The key difference: SoFi Technologies Inc is far larger — about 3.1× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.
| SOFI | TXG | |
|---|---|---|
Market Cap | $23.22B | $7.61B |
Sector | Financials | Health |
52-Week High | $32.21 | $58.57 |
52-Week Low | $15.15 | $11.34 |
Enterprise Value | — | $7.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOFI trades at $18.12, down 1.41% today, with a bullish technical signal and recent earnings beats. Revenue grew to $3.61B in 2025, with a net income margin of 14.78%. The stock is supported by strong member growth and a consensus price target of $19.50, though negative operating cash flow and high valuation ratios present challenges.
Outlook is cautiously optimistic with growth potential from digital banking expansion, but risks include persistent negative cash flow, competitive pressures, and sensitivity to interest rate changes. Analyst sentiment is mixed, with 33% buy ratings highlighting upside, while high P/E of 36.69 warrants caution for value-focused investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
